Merck-Moderna trial and mRNA vaccine: Is this the future of cancer treatment?

Edit ProfileSubscribe NowSaved ArticlesFollowingMy ReadsSign out mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncologyThe Phase 3 INTerpath-001 trial delivered oncology's first personalised cancer vaccine win, and mRNA a therapeutic breakthrough since the pandemic.Published on: Aug 20, 2026, 08:31:20 ISTBy Binayak DasguptaPrefer HTon Google Moderna shares spiked by…